Biopharma & CROs
A better-informed start. Stronger engagement throughout.
People who begin with a clearer understanding are more likely to see the journey through.
What your study gains
Your study benefits from the right person making the right decision to apply for your study. This ensures more productive site conversations, earlier visibility of concerns, and stronger engagement throughout the trial. Recently, using trialport, a study screened 15 people from 19 applications and had 8 people enrol in 6 weeks.
How it works
People find your study
People find your study through a simple search function.
Clear, plain language
Your study is presented as a plain-language summary.
An informed decision
Our proprietary medifit™ + readifit™ self-reflection tools help people considering your trial make a more informed decision about whether it is right for them.
A direct connection
We support people to take the next step when they are ready by making direct connections to clinical sites, reducing the burden on them.
Real-time insight
Your bespoke dashboard gives you real-time insight into how people are engaging with the study, where questions arise, and where further support may be needed.
Why trialport?
trialport looks beyond medical eligibility. It helps create a stronger match between the people considering your trial and what the study asks of them. That means people can make a more informed decision, sites can begin with clearer expectations, and study teams can better understand what may support engagement from beginning to end.
The evidence
Referral quality, before and since.
14.3% 79.1%
The share of people who go on to apply for a trial, before and since the launch of readifit.
When people can see how a study fits their health and their life, they are far better able to decide whether the next step is right for them.
Frequently asked questions
How is trialport different from patient recruitment vendors?
trialport is focused on understanding, readiness and trust. It does not sell leads, push people toward studies or optimize for volume.
What data do sponsors receive?
Sponsors receive aggregated, anonymized insights about engagement and readiness. They do not receive identifiable patient data.
Is trialport compliant with data protection standards?
trialport is designed to align with GDPR, HIPAA and international privacy expectations.
Does this replace site screening processes?
No. Screening and eligibility decisions remain with the research site.
What information does a site receive?
When someone chooses to connect with your site, you receive the information they have chosen to provide as part of their inquiry.
Where medifit™ and readifit™ have been completed, your team can also see the results of those self-reflections. This can provide useful early context around how the person believes they may align with the study’s eligibility criteria, as well as practical considerations, questions, concerns, or areas where additional support may be helpful.
The information is there to help your team understand the person before the first conversation, rather than having to begin completely from scratch.
Importantly, the information provided by trialport is decision support, not a clinical determination. medifit™ does not confirm eligibility, and readifit™ does not determine whether someone should participate. Those conversations and decisions remain between the person and the clinical study team.
Is there a cost for sites to receive inquiries?
No. There is no cost to the clinical trial site to receive or follow up with inquiries through trialport.
Our aim is to make it easier for interested people and research sites to connect, without creating an additional financial barrier for the site.
Once a person chooses to connect, your team can review the information they have provided and follow your usual processes for contacting them, discussing the study, and determining whether formal screening is appropriate.